- Home
- TELA vs SRTS Comparison
TELA vs SRTS Comparison
Compare TELA & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TELA | SRTS |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.0M | 48.9M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TELA | SRTS |
|---|---|---|
| Price | $0.65 | $3.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $2.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 159.7K | 23.0K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.59 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $80,275,000.00 | $27,482,000.00 |
| Revenue This Year | $10.23 | $2.00 |
| Revenue Next Year | $14.26 | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 15.84 | N/A |
| 52 Week Low | $0.50 | $2.66 |
| 52 Week High | $2.00 | $5.49 |
Technical Indicators
Market Signals| Indicator | TELA | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 38.15 | 63.66 |
| Support Level | $0.56 | $2.80 |
| Resistance Level | $0.97 | $3.70 |
| Average True Range (ATR) | 0.10 | 0.15 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 5.71 | 90.26 |
Price Performance
Historical ComparisonAbout TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.